IZI Medical (Shore Capital-backed) Acquires RadioMed Corporation and VISICOIL from IBA S.A.

December 18, 2019

IZI Medical Products, LLC, a Shore Capital Partners-backed interventional radiology device platform, acquired RadioMed Corporation and its VISICOIL fiducial marker product family from IBA S.A. The purchase is an add-on to IZI’s portfolio—its fourth add-on in 24 months—and is intended to expand IZI’s imaging marker and interventional oncology offerings through RadioMed’s distribution channels and IZI’s direct sales force.

Buyers
IZI Medical Products, LLC, Shore Capital Partners, LLC
Targets
RadioMed Corporation
Sellers
IBA S.A.
Platforms
IZI Medical Products, LLC
Industry
Medical Devices
Location
Tennessee, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.